Clinical Study on Guihuang Prescription in Treating Type III Prostatitis (damp heat and blood stasis syndrome)

Not Applicable

Recruiting

• Conditions: chronic prostatitis

• Registration Number: ITMCTR2100004989
• Lead Sponsor: Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

1. Aged 18-50 years; ??
2. Those who meet the diagnostic criteria of type III prostatitis in Western medicine;
3. TCM syndrome differentiation in line with damp-heat stasis syndrome;
4. The disease course exceeds 3 months;
5. Those who have not received other treatments before treatment, those who have received treatment should stop taking the drug for at least 2 weeks;
6. Those who signed the informed consent.

Exclusion Criteria

1. Allergic constitution, those who are allergic to this drug and those who cannot tolerate the drug;
2. Combined with urethritis, acute prostatitis, urinary calculi, urethral stricture, prostate tumor and other diseases;
3. Patients with severe cardiovascular disease, cerebrovascular disease, hypotension, liver and kidney insufficiency, hematopoietic system disease, and mental illness.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ational Institutes of Health Chronic Prostatitis Symptom Index Score;